Jason N. Gorevic - Sep 1, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol: TDOC
Transactions as of: Sep 1, 2023
Transactions value $: -$65,568
Form type: 4
Date filed: 9/6/2023, 04:11 PM
Previous filing: Jul 28, 2023
Next filing: Dec 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+5.61K	+0.94%		602K	Sep 1, 2023	Direct	F1
transaction	TDOC	Common Stock	Sale	-$65.6K	-2.86K	-0.48%	$22.89	599K	Sep 5, 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-5.61K	-14.28%	$0.00	33.7K	Sep 1, 2023	Common Stock	5.61K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.